Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VISIPAQUE for Lymphadenopathy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where VISIPAQUE was used for Lymphadenopathy.

Most Reported Side Effects for VISIPAQUE

Side Effect Reports % Deaths Hosp.
Urticaria 29 21.3% 0 8
Dyspnoea 24 17.7% 0 9
Pruritus 21 15.4% 0 5
Erythema 12 8.8% 0 2
Flushing 10 7.4% 0 4
Hypersensitivity 10 7.4% 0 1
Swelling face 10 7.4% 0 3
Rash 8 5.9% 0 2
Vomiting 8 5.9% 0 2
Nephrogenic systemic fibrosis 7 5.2% 0 0
Rash erythematous 6 4.4% 0 2
Swelling 6 4.4% 0 2
Angioedema 5 3.7% 0 4
Chest pain 5 3.7% 0 3
Cough 5 3.7% 0 2

Other Indications for VISIPAQUE

Diagnostic procedure (111) Product used for unknown indication (43) Abdominal pain (8)

Other Drugs Used for Lymphadenopathy

RITUXIMAB (98) LENALIDOMIDE (84) CYCLOPHOSPHAMIDE (70) VINCRISTINE (56) DOXORUBICIN (46) PREDNISONE (46) IBRUTINIB (43) AMOXICILLIN (42) ETOPOSIDE (29) CLINDAMYCIN (28)

Related Pages

VISIPAQUE Full Profile All Lymphadenopathy Drugs VISIPAQUE Demographics VISIPAQUE Timeline